Novel Biosynthetic Pathways and Fermentation Optimization Drive Scalable Production of Ergothioneine (EGT)

26 Mar 2026
7
Table of Content [Hide]

    Literature Review: Novel Biosynthetic Pathways Enable Scalable Production of Ergothioneine (EGT)

    In recent years, the growing demand for antioxidant and cell-protective ingredients has brought ergothioneine (EGT) into the spotlight across the dietary supplement, functional food, and cosmetic industries.


    Despite its increasing popularity, achieving high-efficiency and cost-effective large-scale production of ergothioneine remains a major challenge for manufacturers. Limitations in natural biosynthetic pathways, complex precursor metabolism, and fermentation costs have all constrained its broader industrial application.


    A recent study published in the Journal of Agricultural and Food Chemistry explored new strategies to improve EGT yields through metabolic engineering and fermentation optimization. The findings provide valuable insights and a promising technical route toward more sustainable and scalable industrial production.


    What Is Ergothioneine and Why Is It Gaining Market Attention?

    Ergothioneine is a naturally occurring sulfur-containing derivative of the amino acid histidine. It has attracted growing interest in recent years due to several unique properties:


    • strong antioxidant activity

    • excellent stability under heat and a wide pH range

    • selective uptake in the human body via the OCTN1 transporter


    Because the human body cannot synthesize ergothioneine on its own, it must be obtained through dietary sources or supplementation. A growing body of research suggests that EGT may have potential applications in:


    • antioxidant and anti-inflammatory formulations

    • neuroprotection and healthy aging products

    • skin repair and anti-photoaging cosmetics


    Following its approval as a novel food ingredient in the European Union, the global market for ergothioneine is expected to expand steadily in the coming years. This regulatory progress has also accelerated demand for high-purity ergothioneine powder suitable for large-scale commercial use.


    Construction and Optimization of a Novel EGT Biosynthetic Pathway

    To improve microbial production of EGT, researchers isolated key biosynthetic genes from Methylobacterium aquaticum and reconstructed the pathway in Escherichia coli. The engineered pathway relies on three core enzymes:


    • EgtB

    • EgtD

    • EgtE


    By adjusting plasmid copy numbers to fine-tune enzyme expression levels, the research team was able to enhance product accumulation. As a result, EGT titers increased from 29.5 mg/L to 35 mg/L, providing a stronger foundation for further metabolic engineering efforts.


    These findings highlight the importance of balancing metabolic flux through precise control of gene expression, which remains a critical strategy for improving ergothioneine fermentation yields.


    figure-1-design-and-optimization-of-the-egt-biosynthetic-pathway.jpg


    Figure 1. Design and optimization of the EGT biosynthetic pathway.(a) Reconstructed ergothioneine biosynthetic pathway derived from Methylobacterium aquaticum DSM 16371.(b) Time-course profiles of EGT production and cell growth (OD600) in strain ECE1.(c) Schematic illustration of plasmid construction used for copy number optimization.(d) Comparison of EGT titers and OD600 values among strains harboring plasmids with different copy numbers.


    Metabolic Engineering of Precursor Amino Acids Significantly Boosts EGT Production

    The biosynthesis of ergothioneine relies on three key amino acid precursors:

    • histidine

    • cysteine

    • methionine


    To further enhance EGT yields, the research team applied targeted metabolic engineering strategies to increase intracellular precursor availability. This was achieved by removing feedback inhibition and redirecting metabolic flux toward amino acid biosynthesis.


    Key modifications included:

    • deletion of metJ, a transcriptional repressor, to enhance methionine biosynthesis

    • introduction of feedback-resistant variants metA^mut and thrA to improve amino acid flux

    • deletion of sdaA to reduce serine degradation and support cysteine formation


    Following these combined genetic modifications, EGT titers increased to 130 mg/L, representing a several-fold improvement over the original strain.

    From an industrial biotechnology perspective, these results underscore that optimizing precursor supply is one of the most effective strategies for improving the efficiency of microbial ergothioneine production.


    figure-2-metabolic-engineering-of-precursor-amino-acids-to-enhance-egt-production.jpg


    Figure 2. Metabolic engineering of precursor amino acids to enhance EGT production.(a) Effect of metJdeletion on EGT titers.(b) Impact of gene overexpression and co-expression on EGT production.(c) Effect of sdaA deletion on EGT accumulation.(d) Influence of increased precursor amino acid supply on EGT yields.


    Low-Cost Media and Fed-Batch Fermentation Enable Scalable Production Breakthrough

    Building on the optimized strains, the research team further refined the fermentation process:

    • Identified 20 g/L as the optimal glucose concentration

    • Replaced yeast extract with corn steep liquor (CSL) to reduce production costs


    Using fed-batch fermentation in a 10 L bioreactor, the process achieved:

    • EGT titer: 595 mg/L

    • Productivity: 8.2 mg/L/h


    These results demonstrate a significant balance between cost efficiency and production yield, providing a practical route for commercial-scale ergothioneine manufacturing.


    figure-3-optimization-of-the-fermentation-process-for-strain-ece14.jpg

    Figure 3: Optimization of the fermentation process for strain ECE14. (a) EGT production at different glucose concentrations. (b) Evaluation of using corn steep liquor (CSL) to replace yeast extract (YE) at various concentrations.


    What This Study Means for the Ergothioneine Industry

    This research delivers three major signals for the ergothioneine market:


    1. EGT fermentation technology is maturing
    The integration of metabolic engineering with process optimization makes microbial fermentation the most competitive route for ergothioneine powder production.


    2. Raw material costs can be further reduced
    Using industrial by-products like corn steep liquor (CSL) instead of yeast extract lowers the cost of bulk ergothioneine, making large-scale production more economically feasible.


    3. Stable supply of high-purity EGT
    As fermentation pathways improve, the industry can gradually move away from natural extraction, ensuring a consistent and scalable supply of EGT.


    For dietary supplement brands, functional food companies, and cosmetic formulators, this trend highlights that ergothioneine powder is increasingly a commercially viable functional ingredient.


    Natural Field: Your Trusted Ergothioneine Supplier

    With growing global demand for antioxidants and cell-protective ingredients, brands prioritize partners who can provide reliable, high-purity ergothioneine.


    Natural Field specializes in functional active ingredients and offers:

    • Premium ergothioneine powder with high purity

    • Consistent quality across all production batches

    • Raw materials suitable for dietary supplements and cosmetic formulations


    As an experienced ergothioneine supplier and EGT manufacturer, we focus not only on scale but also on:

    • Fermentation process optimization

    • Raw material traceability

    • Customizable purity and specifications


    If you are looking for a trusted partner for bulk ergothioneine or want to explore EGT applications in your product line, our technical team can provide detailed information and samples to support your development.

    References

    Novel Biosynthetic Pathways and Fermentation Optimization Drive Scalable Production of Ergothioneine (EGT)
    Dr. Chong Li
    National-level talent scholar recognized by the Ministry of Education; Joint Ph.D. student at the Peptide/Protein Chemistry Laboratory, University of Maryland School of Medicine (Baltimore); Published over 20 SCI research papers
    Rigorous Standard
    Stable Quality
    Fast Delivery
    Contact Us
    Brand Network:
    0
    Inquire Basket
    Empty
    Inquiry
    0
    We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
    Reject Accept